Cipher Pharmaceuticals Inc. (CPHRF) Financials

CPHRF Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 167.8 million 21.9 million
June 30, 2026 156.7 million 19.6 million
March 31, 2026 153.8 million 20.6 million
Dec. 31, 2025 156.2 million 30.2 million

CPHRF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 8.3 million ?
June 30, 2026 3.0 million ?
March 31, 2026 4.5 million 304000
Dec. 31, 2025 8.8 million 525000

CPHRF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 10.7 million
June 30, 2026 3.9 million
March 31, 2026 6.2 million
Dec. 31, 2025 13.5 million

CPHRF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 15.3 million - 339010
June 30, 2026 9.1 million - 124850
March 31, 2026 6.4 million - 428542
Dec. 31, 2025 7.5 million 5.0 million 504606

CPHRF Shares Outstanding

No data available :(

CPHRF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 4777 17697 3.3 million -
June 30, 2026 15528 - 3.4 million -
March 31, 2026 987 - 2.9 million 499000
Dec. 31, 2025 25433 - 4.0 million -

CPHRF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 12.5 million 4.1 million
June 30, 2026 11.8 million 4.0 million
March 31, 2026 12.3 million 4.0 million
Dec. 31, 2025 12.4 million 4.2 million

CPHRF

Price: $9.25

52 week price:
7.47
15.00

Earnings Per Share: 0.67 USD

P/E Ratio: 16.42

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 244.5 million

Links: